Corcept Therapeutics
CORT
#1822
Rank
S$11.98 B
Marketcap
$113.58
Share price
-8.01%
Change (1 day)
226.23%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$0.21 Billion

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are S$0.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.21 B44.29%
2023-12-31S$0.15 B38.63%
2022-12-31S$0.10 B68.73%
2021-12-31S$64.82 M1.25%
2020-12-31S$64.02 M15.46%
2019-12-31S$55.45 M13.34%
2018-12-31S$48.92 M23.71%
2017-12-31S$39.54 M-0.18%
2016-12-31S$39.61 M-16.15%
2015-12-31S$47.25 M-5.94%
2014-12-31S$50.23 M-5.73%
2013-12-31S$53.28 M16.55%
2012-12-31S$45.72 M602.47%
2011-12-31S$6.5 M30.91%
2010-12-31S$4.97 M46.41%
2009-12-31S$3.39 M-17.2%
2008-12-31S$4.1 M-5.31%
2007-12-31S$4.33 M-20.25%
2006-12-31S$5.43 M-8.45%
2005-12-31S$5.93 M99.36%
2004-12-31S$2.97 M-95.95%
2003-12-31S$73.48 M-3.16%
2002-12-31S$75.88 M2075.86%
2001-12-31S$3.48 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$145.86 B 67,377.20%๐Ÿ‡บ๐Ÿ‡ธ USA
S$102.35 B 47,249.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$78.05 B 36,007.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$86.54 B 39,935.85%๐Ÿ‡บ๐Ÿ‡ธ USA
S$167.73 B 77,494.37%๐Ÿ‡บ๐Ÿ‡ธ USA
S$94.99 B 43,843.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.98 B 355.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.63 B 193.64%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.78 B 726.86%๐Ÿ‡บ๐Ÿ‡ธ USA